Ribosomal protein L12 pseudogene 39 (RPL12P39)

Ribosomal protein L12 pseudogene 39 (RPL12P39) is a processed pseudogene, meaning it is a non-functional genomic DNA segment that resembles the nearby functional ribosomal protein L12 gene (RPL12). Pseudogenes such as RPL12P39 arise by reverse transcription and genomic insertion of a messenger RNA copy from a parent gene, lacking regulatory elements and usually containing mutations preventing their translation into functional proteins. RPL12P39 does not encode a functional protein nor does it participate in canonical ribosomal or cellular pathways. Pseudogenes can sometimes affect gene expression of related genes through regulatory effects, but there is no evidence that RPL12P39 itself acts as a clinical or therapeutic target[1][8][5]. It is not a protein-coding gene and does not produce functional ribosomal subunit protein L12. The functional counterpart, ribosomal protein L12 (RPL12), is a component of the 60S subunit of cytoplasmic ribosomes, but RPL12P39 cannot substitute for its function. No evidence in current authoritative sources suggests a disease or therapeutic relevance for RPL12P39—as is typical for most processed pseudogenes. It is included in genome annotations primarily to distinguish it from the functional gene and avoid confusion in experimental or computational analyses. Overall, RPL12P39 is a processed pseudogene with no protein-coding function, no known disease association, and no role as a therapeutic target or biomarker. It is relevant only as an annotation artifact and not as a drug target or functional gene[1][8][5].

Other names

RPL12_20_1611RPL12P39